ArticleActa biochimica et biophysica Sinica2023

SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway.

Minghao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.